A new study shows that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...

Porton Advanced Solutions and EVA Pharma have signed an MoU to enhance the development capabilities for CAR T-cell therapies.

What if a blood test could reveal the pace of our aging - and the diseases that may lie ahead? The labs of Profs. Liran ...

EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 70 countries worldwide. For more ...

Numerous businesses in Acadiana have come together for a benefit being held in support of a local boy, Fisher, and his family ...

NeuroScientific Biopharmaceuticals has acquired unlisted Perth-based Isopogen for $5.1 million, gaining control of the ...

Investigation reveals cancer drugs failing quality tests worldwide, including cisplatin, oxaliplatin, cyclophosphamide, ...

Despite major advances, real-world data show diminishing survival outcomes and treatment-limiting toxicities in second line ...

A Honduran woman filed a lawsuit challenging the legality of her and her family’s detention at a Texas facility. She is also ...

The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell ...

June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as ...

A research team has made a significant finding that sheds new light on dementia with Lewy Bodies (DLB). The team was led by ...